Alternatives to BioChange

Seevix Material Sciences develops and produces SVX, a proprietary spider silk protein, for various industrial and medical applications.

Elevating uterine health through innovative biomaterial therapies.

Developing wearable brain imaging systems using quantum sensing technology.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Developing a minimally invasive, one-time outpatient therapy for obesity treatment.

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

AI-powered breast cancer detection and risk assessment solutions.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Revolutionizing genomic analysis with innovative sequencing technology.

Biotech startup developing laser bioprinting systems for regenerative medicine and biosensor applications.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Pioneering transcatheter technology for tricuspid regurgitation with a novel cross-caval approach.

A global pure-play dermatology company focused on injectable aesthetics, dermatological skincare, and therapeutic medicine.

Self-powered nanogenerator implanted to restore touch sensation by stimulating sensory nerves.

Medical device company developing a regenerative implant for cartilage repair.

Develops minimally invasive bioelectronic solutions for treating low back pain and spinal degeneration.